Abstract

BackgroundLassa virus (LASV) infection causes an acute and sometimes fatal hemorrhagic disease in humans and nonhuman primates; however, little is known about the development of Lassa fever. Here, we performed a pilot study to begin to understand the progression of LASV infection in nonhuman primates.MethodsSix cynomolgus monkeys were experimentally infected with LASV. Tissues from three animals were examined at an early- to mid-stage of disease and compared with tissues from three animals collected at terminal stages of disease.ResultsDendritic cells were identified as a prominent target of LASV infection in a variety of tissues in all animals at day 7 while Kupffer cells, hepatocytes, adrenal cortical cells, and endothelial cells were more frequently infected with LASV in tissues of terminal animals (days 13.5-17). Meningoencephalitis and neuronal necrosis were noteworthy findings in terminal animals. Evidence of coagulopathy was noted; however, the degree of fibrin deposition in tissues was less prominent than has been reported in other viral hemorrhagic fevers.ConclusionThe sequence of pathogenic events identified in this study begins to shed light on the development of disease processes during Lassa fever and also may provide new targets for rational prophylactic and chemotherapeutic interventions.

Highlights

  • Lassa fever (LF) is a severe hemorrhagic fever (HF) that is endemic in West African countries with the highest incidence in the Republic of Guinea, Sierra Leone, Liberia, and Nigeria

  • It is estimated that Lassa virus (LASV) infects over 300,000 individuals per year across this region, causing over 3,000 deaths [1]

  • Animals were inoculated in the caudal thigh with a calculated dose of 3000 plaque forming units (PFU) of LASV (Josiah strain)

Read more

Summary

Introduction

Lassa fever (LF) is a severe hemorrhagic fever (HF) that is endemic in West African countries with the highest incidence in the Republic of Guinea, Sierra Leone, Liberia, and Nigeria. It is estimated that Lassa virus (LASV) infects over 300,000 individuals per year across this region, causing over 3,000 deaths [1]. The case fatality rate for LF is estimated to be approximately 15% in hospitalized patients and has been reported to be greater than 50% in several outbreaks [1,2]. Human infection is associated with contact with a widely distributed and highly commensal rodent, Mastomys natalensis, or by contact with infected patients. Lassa virus (LASV) infection causes an acute and sometimes fatal hemorrhagic disease in humans and nonhuman primates; little is known about the development of Lassa fever. We performed a pilot study to begin to understand the progression of LASV infection in nonhuman primates

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.